NEW YORK--(BUSINESS WIRE)--Cognia Corporation, a next generation provider of information that improves Drug Discovery, announces that Mark Nelson, founder and former CEO of Ovid Corporation, has joined the company as both an advisor and investor. “Cognia has the potential to be both big and meaningful,” said Nelson. “I’m excited to be a part of such an interesting opportunity.”
